Analyst: Denali Therapeutics' Neuroscience Work Could Lead To Near-Term Upside
January 03, 2018 at 11:01 AM EST
A Morgan Stanley analyst predicts near-term upside for the shares of Denali Therapeutics Inc. (NASDAQ: DNLI), thanks to its work in ...